Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Neutralizing epitopes on Clostridioides difficile toxin A revealed by the structures of two camelid VHH antibodies

Journal Article · · Frontiers in Immunology
 [1];  [2];  [1]
  1. University of California, Irvine, CA (United States)
  2. Argonne National Laboratory (ANL), Argonne, IL (United States); Cornell University, Argonne, IL (United States)
Toxin A (TcdA) and toxin B (TcdB) are two key virulence factors secreted by Clostridioides difficile, which is listed as an urgent threat by the CDC. These two large homologous exotoxins are mainly responsible for diseases associated with C. difficile infection (CDI) with symptoms ranging from diarrhea to life threatening pseudomembranous colitis. Single-domain camelid antibodies (VHHs) AH3 and AA6 are two potent antitoxins against TcdA, which when combined with two TcdB-targeting VHHs showed effective protection against both primary and recurrent CDI in animal models. Here, we report the co-crystal structures of AH3 and AA6 when they form complexes with the glucosyltransferase domain (GTD) and a fragment of the delivery and receptor-binding domain (DRBD) of TcdA, respectively. Based on these structures, we find that AH3 binding enhances the overall stability of the GTD and interferes with its unfolding at acidic pH, and AA6 may inhibit the pH-dependent conformational changes in the DRBD that is necessary for pore formation of TcdA. These studies reveal two functionally critical epitopes on TcdA and shed new insights into neutralizing mechanisms and potential development of epitope-focused vaccines against TcdA.
Research Organization:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
National Institute of Allergy and Infectious Diseases (NIAID); National Institute of General Medical Sciences; USDOE Office of Science (SC), Basic Energy Sciences (BES). Scientific User Facilities (SUF)
Grant/Contract Number:
AC02-06CH11357
OSTI ID:
2423539
Journal Information:
Frontiers in Immunology, Journal Name: Frontiers in Immunology Vol. 13; ISSN 1664-3224
Publisher:
Frontiers Research FoundationCopyright Statement
Country of Publication:
United States
Language:
English

References (64)

Shape Complementarity at Protein/Protein Interfaces journal December 1993
Single domain antibodies: promising experimental and therapeutic tools in infection and immunity journal June 2009
Use of fluorescence decay times of 8-ANS-protein complexes to study the conformational transitions in proteins which unfold through the molten globule state journal June 1996
Structural Insights into Rational Design of Single-Domain Antibody-Based Antitoxins against Botulinum Neurotoxins journal February 2020
Inference of Macromolecular Assemblies from Crystalline State journal September 2007
Epitopes and Mechanism of Action of the Clostridium difficile Toxin A-Neutralizing Antibody Actoxumab journal April 2017
Safety, immunogenicity and dose response of VLA84, a new vaccine candidate against Clostridium difficile, in healthy volunteers journal May 2016
Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models journal July 2017
Status of vaccine research and development for Clostridium difficile journal November 2019
Cellular Uptake of Clostridium botulinum C2 Toxin:  Membrane Translocation of a Fusion Toxin Requires Unfolding of Its Dihydrofolate Reductase Domain † journal December 2003
Characterization of Membrane Translocation by Anthrax Protective Antigen journal November 1998
Free R value: a novel statistical quantity for assessing the accuracy of crystal structures journal January 1992
Glucosylation of Rho proteins by Clostridium difficile toxin B journal June 1995
Autocatalytic cleavage of Clostridium difficile toxin B journal March 2007
The role of toxin A and toxin B in Clostridium difficile infection journal September 2010
Frizzled proteins are colonic epithelial receptors for C. difficile toxin B journal September 2016
Crystal structure of Clostridium difficile toxin A journal January 2016
Translocation of botulinum neurotoxin light chain protease through the heavy chain channel journal December 2002
Structural basis for CSPG4 as a receptor for TcdB and a therapeutic target in Clostridioides difficile infection journal June 2021
Sulfated glycosaminoglycans and low-density lipoprotein receptor contribute to Clostridium difficile toxin A entry into cells journal June 2019
Structure of the full-length Clostridium difficile toxin B journal July 2019
Structure of the glucosyltransferase domain of TcdA in complex with RhoA provides insights into substrate recognition journal May 2022
Ability of methotrexate to inhibit translocation to the cytosol of dihydrofolate reductase fused to diphtheria toxin journal January 1996
Clostridium difficile Infection journal April 2015
Single molecule detection of intermediates during botulinum neurotoxin translocation across membranes journal June 2007
Translocation domain mutations affecting cellular toxicity identify the Clostridium difficile toxin B pore journal February 2014
The Enterotoxin from Clostridium difficile (ToxA) Monoglucosylates the Rho Proteins journal June 1995
Low pH-induced Formation of Ion Channels by Clostridium difficile Toxin B in Target Cells journal January 2001
Structural Determinants of Clostridium difficile Toxin A Glucosyltransferase Activity journal January 2012
Structural Basis for Antibody Recognition in the Receptor-binding Domains of Toxins A and B from Clostridium difficile journal December 2013
Mechanism of Action and Epitopes of Clostridium difficile Toxin B-neutralizing Antibody Bezlotoxumab Revealed by X-ray Crystallography journal May 2014
Use of a neutralizing antibody helps identify structural features critical for binding of Clostridium difficile toxin TcdA to the host cell surface journal July 2017
A neutralizing antibody that blocks delivery of the enzymatic cargo of Clostridium difficile toxin TcdB into host cells journal November 2017
Auto-catalytic Cleavage of Clostridium difficile Toxins A and B Depends on Cysteine Protease Activity journal June 2007
Stability of isolated antibody-antigen complexes as a predictive tool for selecting toxin neutralizing antibodies journal September 2016
Current Trends in the Epidemiology and Outcomes of Clostridium difficile Infection journal April 2015
Intravenous adenovirus expressing a multi-specific, single-domain antibody neutralizing TcdA and TcdB protects mice from Clostridium difficile infection journal August 2016
A Novel Multivalent, Single-Domain Antibody Targeting TcdA and TcdB Prevents Fulminant Clostridium difficile Infection in Mice journal March 2014
Coot model-building tools for molecular graphics journal November 2004
MolProbity : all-atom structure validation for macromolecular crystallography journal December 2009
XDS journal January 2010
PHENIX: a comprehensive Python-based system for macromolecular structure solution journal January 2010
Overview of the CCP 4 suite and current developments journal March 2011
Phaser crystallographic software journal July 2007
Receptor binding mechanisms of Clostridioides difficile toxin B and implications for therapeutics development journal December 2021
Structural determinants for membrane insertion, pore formation and translocation of Clostridium difficile toxin B: Pore formation of C. difficile toxin B journal January 2011
Structural basis for selective modification of Rho and Ras GTPases by Clostridioides difficile toxin B journal October 2021
A probiotic yeast-based immunotherapy against Clostridioides difficile infection journal October 2020
A Tetraspecific VHH-Based Neutralizing Antibody Modifies Disease Outcome in Three Animal Models of Clostridium difficile Infection journal July 2016
A Chimeric Toxin Vaccine Protects against Primary and Recurrent Clostridium difficile Infection journal May 2012
Oral Immunization with Nontoxigenic Clostridium difficile Strains Expressing Chimeric Fragments of TcdA and TcdB Elicits Protective Immunity against C. difficile Infection in Both Mice and Hamsters journal November 2018
Antibody-Enhanced, Fc Gamma Receptor-Mediated Endocytosis of Clostridium difficile Toxin A journal June 2009
Critical Roles of Clostridium difficile Toxin B Enzymatic Activities in Pathogenesis journal November 2014
Mechanisms of Protection against Clostridium difficile Infection by the Monoclonal Antitoxin Antibodies Actoxumab and Bezlotoxumab journal December 2014
pH-Induced Conformational Changes in Clostridium difficile Toxin B journal May 2000
Nanobodies: Natural Single-Domain Antibodies journal June 2013
Clostridium difficile Toxin Biology journal September 2017
Clostridial Glucosylating Toxins Enter Cells via Clathrin-Mediated Endocytosis journal May 2010
High‐resolution structure of native toxin A from Clostridioides difficile journal November 2021
Structure and conformational dynamics of Clostridioides difficile toxin A journal March 2022
Bivalent Llama Single-Domain Antibody Fragments against Tumor Necrosis Factor Have Picomolar Potencies due to Intramolecular Interactions journal July 2017
Two VHH Antibodies Neutralize Botulinum Neurotoxin E1 by Blocking Its Membrane Translocation in Host Cells journal September 2020
The Role of Rho GTPases in Toxicity of Clostridium difficile Toxins journal December 2015
Clostridium difficile Infection: A Worldwide Disease journal January 2014

Similar Records

Structural basis for selective modification of Rho and Ras GTPases by Clostridioides difficile toxin B
Journal Article · Thu Oct 21 20:00:00 EDT 2021 · Science Advances · OSTI ID:1831265

Structure and conformational dynamics of Clostridioides difficile toxin A
Journal Article · Mon Mar 14 20:00:00 EDT 2022 · Life Science Alliance · OSTI ID:1863966